Article 20 of Regulation (EC) No 1107/2009 applies.

F4...

F5For the purposes of assessment of the approval criteria set out in points 3.6.5 and 3.8.2 of Annex 2 to Regulation (EC) No 1107/2009, the assessing competent authority may decide whether additional information is required and request the applicant to submit such information to the F6assessing competent authority and the other competent authorities in the form of an updated supplementary dossier including the additional information. The F7assessing competent authority shall, in consultation with F8... the applicant, set a period for the submission of that information. Such period shall be at least of 3 months, shall not exceed 30 months, and shall be justified in relation to the type of information which has to be submitted.

Within this period set by the F9assessing competent authority, the applicant may also submit where applicable, documentary evidence showing that the conditions for the application of the derogation under Article 4(7) of Regulation (EC) No 1107/2009 are met.

Where the F10assessing competent authority is able to conclude without requesting additional information that the scientific criteria for the determination of endocrine disrupting properties set out in point 3.6.5 and/or point 3.8.2 of Annex II to Regulation (EC) No 1107/2009 are met, it shall inform the applicant. Within 3 months after being informed by the F11assessing competent authority, the applicant may submit to the F12assessing competent authority and the other competent authorities additional information to address the approval criteria set out in point 3.6.5 and/or point 3.8.2 of Annex II to Regulation (EC) No 1107/2009, and/or documentary evidence showing that the conditions for the application of the derogation under Article 4(7) of that Regulation are met.

The F13assessing competent authority shall, within 90 days from the date of receipt of the additional information evaluate the information received and F14circulate to the other competent authorities and the applicant a revised draft renewal assessment report. The F15assessing competent authority shall conduct a consultation of the revised renewal assessment report with F16the other competent authorities and the applicant in accordance with Article 12.

The F17assessing competent authority shall adopt an addendum to the conclusion referred to in paragraph 1, within 120 days from the date of F18circulation of the revised draft renewal assessment report, using the guidance for identification of endocrine disruptors applicable at the date of the submission of the updated supplementary dossier referred to in the second subparagraph.

Where no additional information is submitted in accordance with the second, the third or the fourth subparagraph within the period set for its submission, the F19assessing competent authority shall, without delay, inform the applicant F20and the other competent authorities and conclude the assessment based on the available information within 30 days from the expiry of the period referred to in the second or fourth subparagraph.

Information submitted by the applicant without having been requested, or provided after the expiry of the period set for its submission in accordance with the second or fourth subparagraph of this Article, shall not be taken into account, unless it is submitted in accordance with Article 56 of Regulation (EC) No 1107/2009.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .